Product image of Monopost (Latanoprost) supplied by GNH India

Monopost

Active Ingredient:
Latanoprost
Origin:
EU

Monopost (Latanoprost)

Latanoprost, the active ingredient in Monopost, is a prostaglandin analog presented as an ophthalmic solution for ocular use. It lowers intra‑ocular pressure and is employed in the management of glaucoma and ocular hypertension in adult patients.

GNH India supplies Monopost as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across markets. The company leverages a robust distribution network to meet the demand of eye‑care professionals globally, and all shipments are accompanied by full documentation and temperature‑controlled packaging where required.

Manufacturer / TM Owner

Laboratoires Thea

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Latanoprost acts on the prostaglandin pathway to reduce intraocular pressure in glaucoma‑related conditions.
  • Open-angle glaucoma: lowers intraocular pressure to prevent optic nerve damage
  • Ocular hypertension: reduces elevated eye pressure to lower risk of glaucoma development
  • Elevated intraocular pressure: decreases pressure to protect visual function

How It Works

  • Latanoprost is a synthetic analogue of prostaglandin F2α that binds to FP receptors in the ciliary body. Activation of these receptors remodels the extracellular matrix, enhancing uveoscleral outflow of aqueous humor. The increased outflow lowers intra‑ocular pressure, providing therapeutic control of glaucoma and ocular hypertension. This effect is sustained with once‑daily dosing, and the drug’s high affinity for ocular tissues ensures localized action with minimal systemic exposure.

Side Effects

Latanoprost may cause ocular and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects

  • Eye redness: transient hyperemia of the conjunctiva.
  • Eye irritation: burning or stinging sensation after instillation.
  • Increased iris pigmentation: gradual darkening of the eye colour.
  • Eyelash changes: lengthening and increased thickness of eyelashes.

Serious or Rare Side Effects

  • Uveitis: inflammation of the uveal tract requiring medical attention.
  • Macular edema: swelling of the central retina that can impair vision.

Precautions & Warnings

Before initiating Latanoprost therapy, consider the following precautions to ensure safe and effective use.

  • Monitor intraocular pressure: schedule regular IOP measurements to assess response.
  • Assess for ocular infections: avoid use in eyes with active bacterial or viral infection.
  • Discontinue contact lens wear: remove lenses before and for several hours after instillation.
  • Pregnancy and lactation: safety unknown; prescribe only if potential benefit outweighs risk.
  • Store at room temperature: keep in original container, protect from light and moisture.

Avoid Interactions

Latanoprost can interact with other ophthalmic or systemic agents, influencing efficacy or safety.

Major Interactions (Avoid)

  • Combined use with other prostaglandin analogues: may cause excessive IOP lowering and hypotony.
  • Concurrent topical NSAIDs: may diminish Latanoprost’s IOP‑lowering effect.
  • Systemic carbonic anhydrase inhibitors: increased risk of ocular side effects.

Moderate Interactions (Monitor Closely)

  • Beta‑blocker eye drops: additive IOP reduction may require monitoring.
  • Alpha‑adrenergic agonist drops: potential alteration of pressure‑control dynamics.

Frequently Asked Questions

Monopost contains Latanoprost and is prescribed to lower intra‑ocular pressure in patients with open‑angle glaucoma or ocular hypertension. By reducing pressure within the eye, it helps prevent optic‑nerve damage and preserves visual function.

Latanoprost mimics prostaglandin F2α and binds to FP receptors in the eye’s ciliary body. This binding remodels extracellular matrix proteins, increasing uveoscleral outflow of aqueous humor, which in turn lowers intra‑ocular pressure.

The dosing regimen for Monopost is determined by the prescribing clinician. Typically, a single drop is instilled in the affected eye(s) once daily in the evening, but the exact dose and timing should follow the prescriber’s instructions.

Safety data for Latanoprost in pregnancy and lactation are limited. It is classified as pregnancy category unknown, so it should only be used when the potential benefit justifies any possible risk to the fetus or infant.

To order Monopost, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Monopost (Latanoprost) belongs to the prostaglandin analogue class, which generally offers once‑daily dosing and a favorable efficacy profile compared with beta‑blockers or carbonic anhydrase inhibitors. It is often preferred for its potent IOP‑lowering effect and convenient dosing schedule.

Monopost should be stored at room temperature, below 25 °C, in its original container. Protect the bottle from light and moisture, and keep it out of reach of children. Do not freeze the product.

Monopost is applied as an ophthalmic solution. The patient should wash hands, tilt the head back, pull down the lower eyelid, and place a single drop into the conjunctival sac. Close the eye gently and avoid blinking excessively for a few minutes.

Serious adverse events, although rare, include uveitis and macular edema, both of which can threaten vision and require prompt medical evaluation. Any sudden loss of vision, eye pain, or severe inflammation should be reported immediately.

Monopost is contraindicated in patients with known hypersensitivity to Latanoprost or any component of the formulation, and it should be avoided in eyes with active intra‑ocular infection or inflammation until the condition is resolved.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Latanoprost

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT